CHICAGO (Reuters) - A simple enzyme may hold the key to tackling a hard-to-treat type of leukemia in babies, U.S. researchers said on Monday.
CHICAGO (Reuters) - A simple enzyme may hold the key to tackling a hard-to-treat type of leukemia in babies, U.S. researchers said on Monday.